Control of Drug Administration

• US 20080108970A1
• Filed: 11/08/2006
• Published: 05/08/2008
• Est. Priority Date: 11/08/2006
• Status: Abandoned Application

• Current Assignee: General Electric Company
• Original Assignee: General Electric Company
• Inventors: Viertio-Oja, Hanna E.
• Application Number:
  US11/557,635
• Publication Number:
  US 20080108970A1
• Time in Patent Office: Days
• US Class Current: 604/512
• CPC Class Codes: G16H 40/63 for local operation

Abstract

The invention relates to a method and apparatus for controlling drug administration. In order to achieve an easy-to-use and technically reliable control mechanism that can be implemented cost-effectively, input information including patient information and effect level information for at least one type of drug effect to be achieved in a patient is supplied to the control mechanism. Synergetic pharmacodynamic models are utilized to determine, based on the input information, effect-site concentration(s) for at least one drug to be administered. A pharmacokinetic model of each drug may then be utilized to define, based on the effect-site concentration of the drug, a delivery rate for the drug to be administered.

Claims

1. A method for controlling drug administration, the method comprising:

receiving input information for drug administration, wherein the input information includes patient information and effect level information for at least one type of drug effect to be achieved in a patient; and

defining, based on the input information and at least one pharmacodynamic model, an effect-site concentration for a drug to be administered.

2. A method according to claim 1, wherein the defining is performed for each drug to be administered.

3. A method according to claim 1, further comprising determining, based on the effect-site concentration of the drug and a pharmacokinetic model of the drug, a delivery rate for the drug.

4. A method according to claim 3, wherein the determining is performed for each drug to be administered.

5. A method according to claim 1, wherein the defining includes choosing, based on the at least one type of drug effect, at least one drug to be administered.

6. A method according to claim 5, wherein the patient information indicates the weight and height of the patient.

7. A method according to claim 1, wherein the patient information indicates the weight and height of the patient and the input information further includes drug information indicating at least one drug to be administered.

8. A method according to claim 1, wherein the effect level information includes at least one effect level value within a predetermined effect scale.

9. A method according to claim 8, wherein the at least one effect level value is one of a plurality of predetermined effect levels.

10. A method according to claim 1, wherein the at least one pharmacodynamic model incorporates synergetic effects of at least two drugs.

11. A method according to claim 3, further comprising administering at least one drug in response to the determining, wherein each of the at least one drug is administered at the delivery rate determined for that drug.

12. A method according to claim 1, wherein the at least one type of drug effect belongs to a group including a hypnotic effect, an analgesic effect, and a neuromuscular blocking effect.

13. A method according to claim 1, further comprising supplying the effect-site concentration as input information to a TCI pump.

14. A method according to claim 8, further comprising providing a user interface module configured to display the predetermined effect scale and to enable a user to select the at least one effect level value from the predetermined effect scale.

15. A method according to claim 14, wherein the user interface module is further configured to display at least one statistical reference curve indicating how the proportion of patients responding in a certain manner changes as the at least one effect level value changes.

16. An apparatus for controlling drug administration, the apparatus comprising

a user interface module configured to receive input information for drug administration, wherein the input information includes patient information and effect level information for at least one type of drug effect to be achieved in a patient;

a computation module configured to define, based on the input information and at least one pharmacodynamic model, an effect-site concentration for a drug to be administered.

17. An apparatus according to claim 16, wherein the computation module is further configured to determine, based on the effect-site concentration of the drug and a pharmacokinetic model of the drug, a delivery rate for the drug.

18. An apparatus according to claim 16, wherein the computation module is configured to choose, based on the at least one type of drug effect, at least one drug to be administered.

19. An apparatus according to claim 16, wherein the at least one pharmacodynamic model incorporates synergetic effects between at least two drugs.

20. An apparatus according to claim 16, wherein the at least one type of drug effect belongs to a group including a hypnotic effect, an analgesic effect, and a neuromuscular blocking effect.

21. An apparatus according to claim 16, wherein the computation module is further configured to supply the effect-site concentration as input information to a TCI pump.

22. An apparatus according to claim 16, wherein the user interface module comprises a display unit configured to display a predetermined effect scale for the at least one type of drug effect, and wherein the user interface module is configured to enable a user of the apparatus to select at least one value from the predetermined effect scale.

23. An apparatus for controlling drug administration, the apparatus comprising

user interface means for receiving input information for drug administration, wherein the input information includes patient information and effect level information for at least one type of drug effect to be achieved in a patient;

computation means for defining, based on the input information and at least one pharmacodynamic model, an effect-site concentration for a drug to be administered.

24. An apparatus according to claim 23, wherein the computation means are configured to determine, based on the effect-site concentration of the drug and a pharmacokinetic model of the drug, a delivery rate for the drug.

25. A computer program product for controlling drug administration, the computer product comprising:

a first program code portion configured to receive input information for drug administration, wherein the input information includes patient information and effect level information for at least one type of drug effect to be achieved in a patient;

a second program code portion configured to define, based on the input information and at least one pharmacodynamic model, an effect-site concentration for a drug to be administered.

26. A computer program product according to claim 25, further comprising a third program code portion configured to determine, based on the effect-site concentration of the drug and a pharmacokinetic model of the drug, a delivery rate for the drug.